Theranostic approach to specifically targeting the interloop region of BCL2 i-motif DNA by crystal violet

Sci Rep. 2023 Sep 1;13(1):14338. doi: 10.1038/s41598-023-39407-9.

Abstract

Ligands that recognise specific i-motif DNAs are helpful in cancer diagnostics and therapeutics, as i-motif formation can cause cancer. Although the loop regions of i-motifs are promising targets for ligands, the interaction between a ligand and the loop regions based on sequence information remains unexplored. Herein, we investigated the loop regions of various i-motif DNAs to determine whether these regions specifically interact with fluorescent ligands. Crystal violet (CV), a triphenylmethane dye, exhibited strong fluorescence with the i-motif derived from the promoter region of the human BCL2 gene in a sequence- and structure-specific manner. Our systematic sequence analysis indicated that CV was bound to the site formed by the first and third loops through inter-loop interactions between the guanine bases present in these loops. As the structural stability of the BCL2 i-motif was unaffected by CV, the local stabilisation of the loops by CV could inhibit the interaction of transcription factors with these loops, repressing the BCL2 expression of MCF-7 cells. Our finding suggests that the loops of the i-motif can act as a novel platform for the specific binding of small molecules; thus, they could be utilised for the theranostics of diseases associated with i-motif DNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coloring Agents
  • DNA
  • Gentian Violet*
  • Humans
  • Ligands
  • Precision Medicine*
  • Proto-Oncogene Proteins c-bcl-2

Substances

  • Gentian Violet
  • Ligands
  • Coloring Agents
  • DNA
  • Proto-Oncogene Proteins c-bcl-2
  • BCL2 protein, human